Modulation of reactivation of latent herpes simplex virus 1 in ganglionic organ cultures by p300/CBP and STAT3

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 28, 2013, Pages

  Du, Te ^a   Zhou, Guoying ^a   Roizman, Bernard ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Latency associated transcript; Nerve growth factor

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 4; LONG UNTRANSLATED RNA; MICRORNA; PHENYLALANINE; STAT3 PROTEIN; TYROSINE;

ARTICLE; EMOTIONAL STRESS; ENZYME INHIBITION; GENE EXPRESSION; HERPES SIMPLEX VIRUS 1; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VIRUS INHIBITION; VIRUS REACTIVATION;

LATENCY-ASSOCIATED TRANSCRIPT; NERVE GROWTH FACTOR;

GANGLIA; HERPESVIRUS 1, HUMAN; HUMANS; ORGAN CULTURE TECHNIQUES; P300-CBP TRANSCRIPTION FACTORS; STAT3 TRANSCRIPTION FACTOR; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 84879991067     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1309906110     Document Type: Article

References (45)

1. Roizman B, Knipe DM, Whitley RJ (2013) Herpes simplex viruses. Fields Virology, eds Knipe DM, Howley PM (Lippincott Williams & Wilkins, Philadelphia), 6th Ed.
2. Al-Dujaili LJ, et al. (2011) Ocular herpes simplex virus: How are latency, reactivation, recurrent disease and therapy interrelated? Future Microbiol 6(8):877-907.
3. Roizman B, Sears AE (1987) An inquiry into the mechanisms of herpes simplex virus latency. Annu Rev Microbiol 41:543-571.
4. Perng GC, Jones C (2010) Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle. Interdiscip Perspect Infect Dis 2010:262415.
5. Knipe DM, et al. (2013) Snapshots: Chromatin control of viral infection. Virology 435(1):141-156.
6. Farrell MJD, Dobson AT, Feldman LT (1991) Herpes simplex virus latency-associated transcript is a stable intron. Proc Natl Acad Sci USA 88(3):790-794. (Pubitemid 21916109)
7. Spivack JG, Woods GM, Fraser NW (1991) Identification of a novel latency-specific splice donor signal within the herpes simplex virus type 1 2.0-kilobase latency-associated transcript (LAT): Translation inhibition of LAT open reading frames by the intron within the 2.0-kilobase LAT. J Virol 65(12):6800-6810.
8. Mitchell W, Lirette R, Fraser N (1990) Mapping of low abundance latency-associated RNA in the trigeminal ganglia of mice latently infected with hepes simplex virus type 1. J Gen Virol 71(Pt1):125-132. (Pubitemid 20046017)
9. Held K, Derfuss T (2011) Control of HSV-1 latency in human trigeminal ganglia: Current overview. J Neurovirol 17(6):518-527.
10. Cui C, et al. (2006) Prediction and identification of herpes simplex virus 1-encoded microRNAs. J Virol 80(11):5499-5508.
11. Umbach JL, et al. (2008) MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454(7205):780-783.
12. Munson DJ, Burch AD (2012) A novel miRNA produced during lytic HSV-1 infection is important for efficient replication in tissue culture. Arch Virol 157(9):1677-1688.
13. Steiner I (2011) Herpes simplex virus encephalitis: New infection or reactivation? Curr Opin Neurol 24(3):268-274.
14. Farooq AV, Shukla D (2012) Herpes simplex epithelial and stromal keratitis: An epidemiologic update. Surv Ophthalmol 57(5):448-462.
15. Wilson SS, et al. (2009) Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: Expansion of a murine model of microbicide safety. Antivir Ther 14(8):1113-1124.
16. Kaushic C, Nazli A, Ferreira VH, Kafka JK (2011) Primary human epithelial cell culture system for studying interactions between female upper genital tract and sexually transmitted viruses, HSV-2 and HIV-1. Methods 55(2):114-121.
17. Du T, Zhou G, Khan S, Gu H, Roizman B (2010) Disruption of HDAC/CoREST/REST repressor by dnREST reduces genome silencing and increases virulence of herpes simplex virus. Proc Natl Acad Sci USA 107(36):15904-15909.
18. Zhou G, Du T, Roizman B (2013) HSV carrying WT REST establishes latency but reactivates only if the synthesis of REST is suppressed. Proc Natl Acad Sci USA 110(6):E498-E506.
19. Du T, Zhou G, Roizman B (2011) HSV-1 gene expression from reactivated ganglia is disordered and concurrent with suppression of latency-associated transcript and miRNAs. Proc Natl Acad Sci USA 108(46):18820-18824.
20. Roizman B, Gu H, Mandel G (2005) The first 30 minutes in the life of a virus: UnREST in the nucleus. Cell Cycle 4(8):1019-1021. (Pubitemid 41365354)
21. Roizman B, Zhou G, Du T (2011) Checkpoints in productive and latent infections with herpes simplex virus 1: Conceptualization of the issues. J Neurovirol 17(6):512-517.
22. Proença JT, et al. (2011) An investigation of herpes simplex virus promoter activity compatible with latency establishment reveals VP16-independent activation of immediate-early promoters in sensory neurones. J Gen Virol 92(Pt 11):2575-2585.
23. Gu H, Roizman B (2007) Herpes simplex virus-infected cell protein 0 blocks the silencing of viral DNA by dissociating histone deacetylases from the CoREST-REST complex. Proc Natl Acad Sci USA 104(43):17134-17139. (Pubitemid 350211004)
24. Du T, Zhou G, Roizman B (2012) Induction of apoptosis accelerates reactivation of latent HSV-1 in ganglionic organ cultures and replication in cell cultures. Proc Natl Acad Sci USA 109(36):14616-14621.
25. Danaher RJ, Jacob RJ, Steiner MR, Allen WR, Hill JM, Miller CS (2005) Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript (LAT)-independent manner in neuronal cells. J Neurovirol 11(3):306-317. (Pubitemid 41122419)
26. Kazantsev AG, Thompson LM (2008) Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov 7(10):854-868.
27. Nebbioso A, et al. (2009) Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes. EMBO Rep 10(7):776-782.
28. Khan N, et al. (2008) Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem J 409(2):581-589. (Pubitemid 351184977)
29. Balasubramanyam K, Swaminathan V, Ranganathan A, Kundu TK (2003) Small molecule modulators of histone acetyltransferase p300. J Biol Chem 278(21):19134-19140. (Pubitemid 36799302)
30. Balasubramanyam K, et al. (2004) Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 279(49):51163-51171. (Pubitemid 40017859)
31. Siddiquee K, et al. (2007) Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc Natl Acad Sci USA 104(18):7391-7396. (Pubitemid 47185916)
32. Kriesel JD, Jones BB, Hwang IP, Dahms KM, Spruance SL (2001) Signal transducers and activators of transcription (Stat) are detectable in mouse trigeminal ganglion neurons. J Interferon Cytokine Res 21(6):445-450. (Pubitemid 32692467)
33. Nadiminty N, et al. (2006) Stat3 activation of NF-kappaB p100 processing involves CBP/p300-mediated acetylation. Proc Natl Acad Sci USA 103(19):7264-7269. (Pubitemid 43727821)
34. Cheng PY, et al. (2011) Interplay between SIN3A and STAT3 mediates chromatin conformational changes and GFAP expression during cellular differentiation. PLoS ONE 6(7):e22018.
35. Al Zaid Siddiquee K, Turkson J (2008) STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Res 18(2):254-267. (Pubitemid 351206162)
36. Catlett-Falcone R, et al. (1999) Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10(1):105-115. (Pubitemid 29077388)
37. Aoki Y, Feldman GM, Tosato G (2003) Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 101(4):1535-1542. (Pubitemid 36182531)
38. Li GH, et al. (2009) STAT3 silencing with lentivirus inhibits growth and induces apoptosis and differentiation of U251 cells. J Neurooncol 91(2):165-174.
39. Lee N, Neitzel KL, Devlin BK, MacLennan AJ (2004) STAT3 phosphorylation in injured axons before sensory and motor neuron nuclei: Potential role for STAT3 as a retrograde signaling transcription factor. J Comp Neurol 474(4):535-545. (Pubitemid 38720423)
40. Dziennis S, Alkayed NJ (2008) Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration. Rev Neurosci 19(4-5):341-361.
41. Pranada AL, Metz S, Herrmann A, Heinrich PC, Müller-Newen G (2004) Real time analysis of STAT3 nucleocytoplasmic shuttling. J Biol Chem 279(15):15114-15123. (Pubitemid 38618906)
42. Kubat NJ, Tran RK, McAnany P, Bloom DC (2004) Specific histone tail modification and not DNA methylation is a determinant of herpes simplex virus type 1 latent gene expression. J Virol 78(3):1139-1149. (Pubitemid 38095824)
43. Kwiatkowski DL, Thompson HW, Bloom DC (2009) The polycomb group protein Bmi1 binds to the herpes simplex virus 1 latent genome and maintains repressive histone marks during latency. J Virol 83(16):8173-8181.
44. Bloom DC, Giordani NV, Kwiatkowski DL (2010) Epigenetic regulation of latent HSV-1 gene expression. Biochim Biophys Acta 1799(3-4):246-256.
45. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663-676. (Pubitemid 44233629)